Cancer Institute A national cancer institute
designated cancer center

Christopher H. Contag

Publication Details

  • Silencing of Reporter Gene Expression in Skin Using siRNAs and Expression of Plasmid DNA Delivered by a Soluble Protrusion Array Device (PAD) MOLECULAR THERAPY Gonzalez-Gonzalez, E., Speaker, T. J., Hickerson, R. P., Spitler, R., Flores, M. A., Leake, D., Contag, C. H., Kaspar, R. L. 2010; 18 (9): 1667-1674

    Abstract:

    Despite rapid progress in the development of potent and selective small interfering RNA (siRNA) agents for skin disorders, translation to the clinic has been hampered by the lack of effective, patient-friendly delivery technologies. The stratum corneum poses a formidable barrier to efficient delivery of large and/or charged macromolecules including siRNAs. Intradermal siRNA injection results in effective knockdown of targeted gene expression but is painful and the effects are localized to the injection site. The use of microneedle arrays represents a less painful delivery method and may have utility for the delivery of nucleic acids, including siRNAs. For this purpose, we developed a loadable, dissolvable protrusion array device (PAD) that allows skin barrier penetration. The PAD tips dissolve upon insertion, forming a gel-like plug that releases functional cargo. PAD-mediated delivery of siRNA (modified for enhanced stability and cellular uptake) resulted in effective silencing of reporter gene expression in a transgenic reporter mouse model. PAD delivery of luciferase reporter plasmids resulted in expression in cells of the ear, back, and footpad skin as assayed by intravital bioluminescence imaging. These results support the use of PADs for delivery of functional nucleic acids to cells in the skin with an efficiency that may support clinical translation.

    View details for DOI 10.1038/mt.2010.126

    View details for Web of Science ID 000281502300013

    View details for PubMedID 20571543

Stanford Medicine Resources:

Footer Links: